Esperion Therapeutics is being taken private by ARCHIMED in a $1.1 billion dealPharmaBy Colleen Cabili
Atlassian stock jumps 20% after beating revenue and earnings expectationsBusiness NewsBy Colleen Cabili
Tesla reported $158 billion in Elon Musk compensation for 2025 — but he realized none of itAutosBy Colleen Cabili
Meta is threatening to shut down in New Mexico after $375 million child safety verdictBusiness NewsBy Colleen Cabili
Cigna is pulling out of the Obamacare marketplace, leaving 369,000 people to find new coverageBusiness NewsBy Colleen Cabili
Occidental Petroleum is replacing its CEO with a company insider as she retiresBusiness NewsBy Colleen Cabili
13 states are now fighting to block Nexstar's $6.2 billion local TV mergerBusiness NewsBy Colleen Cabili
FDA approves first non-antipsychotic drug for Alzheimer's agitation, driving Axsome shares up 12%PharmaBy Colleen Cabili
Cboe is cutting 20% of its workforce to focus on core exchange businessesBusiness NewsBy Colleen Cabili
